Back to Journals » Open Access Journal of Clinical Trials » Volume 12

Remdesivir is Effective for Moderately Severe Patients: A Re-Analysis of the First Double-Blind, Placebo-Controlled, Randomized Trial on Remdesivir for Treatment of Severe COVID-19 Patients Conducted in Wuhan City

Total article views   Abstract views HTML views PDF downloads Totals
1,981 Dovepress* 1,426 555+ 493 1,981
Totals 1,426 555 493 1,981
*Since 30 July 2020
+Since July 2016

View citations on Google Scholar